Adagene Inc. American Depositary Shares
Symbol: ADAG (NASDAQ)
1.77
▼ (-1.12%) -0.020
Company Description:
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.
Key Stats
- Today's Open: $1.78
- Today's High: $1.825
- Today's Low: $1.755
- Today's Volume: 3.65K
- Yesterday Close: $1.79
- Yesterday High: $1.82
- Yesterday Low: $1.72
- Yesterday Volume: 38.51K
- Last Min Volume: 1
- Last Min High: $1.77
- Last Min Low: $1.77
- Last Min VWAP: $1.77
Company Profile
- Name: Adagene Inc. American Depositary Shares
- Website: https://www.adagene.com
- Listed Date: 2021-02-09
- Location: ,
- Market Status: Active
- CIK Number: 0001818838
- SIC Code:
- SIC description:
- Market Cap: $89.08M
- Round Lot: 100
- Outstanding Shares: 47.13M
- Asset Type: ADRC
RECENT FILINGS FOR ADAG
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-12 | 6-K | View |
| 2025-07-15 | 6-K | View |
| 2025-07-02 | SCHEDULE 13G/A | View |
| 2025-07-01 | 6-K | View |
| 2025-05-30 | EFFECT | View |
| 2025-05-30 | 424B5 | View |
| 2025-05-28 | CORRESP | View |
| 2025-05-23 | CORRESP | View |
| 2025-05-23 | F-3/A | View |
| 2025-05-22 | 6-K | View |
| 2025-05-21 | UPLOAD | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-12 | SCHEDULE 13G/A | View |
| 2025-05-09 | F-3 | View |
| 2025-03-24 | 20-F | View |
| 2025-03-24 | 6-K | View |
| 2025-02-19 | SCHEDULE 13D/A | View |
| 2025-02-14 | SCHEDULE 13G/A | View |
| 2025-02-12 | SCHEDULE 13G/A | View |
| 2025-02-04 | SCHEDULE 13G | View |
Latest News on ADAG